nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunitrazepam—UGT2B7—Epirubicin—sarcoma	0.187	0.194	CbGbCtD
Flunitrazepam—CYP2B6—Thiotepa—sarcoma	0.18	0.187	CbGbCtD
Flunitrazepam—UGT1A1—Etoposide—sarcoma	0.126	0.131	CbGbCtD
Flunitrazepam—CYP2E1—Dacarbazine—sarcoma	0.101	0.105	CbGbCtD
Flunitrazepam—CYP2E1—Mitoxantrone—sarcoma	0.0784	0.0814	CbGbCtD
Flunitrazepam—CYP1A2—Dacarbazine—sarcoma	0.0585	0.0607	CbGbCtD
Flunitrazepam—CYP3A4—Thiotepa—sarcoma	0.0553	0.0574	CbGbCtD
Flunitrazepam—CYP2E1—Etoposide—sarcoma	0.0495	0.0513	CbGbCtD
Flunitrazepam—CYP2B6—Doxorubicin—sarcoma	0.0333	0.0345	CbGbCtD
Flunitrazepam—CYP1A2—Etoposide—sarcoma	0.0286	0.0297	CbGbCtD
Flunitrazepam—CYP3A4—Mitoxantrone—sarcoma	0.0238	0.0247	CbGbCtD
Flunitrazepam—CYP3A4—Vincristine—sarcoma	0.0164	0.017	CbGbCtD
Flunitrazepam—CYP3A4—Etoposide—sarcoma	0.015	0.0156	CbGbCtD
Flunitrazepam—CYP3A4—Doxorubicin—sarcoma	0.0102	0.0106	CbGbCtD
Flunitrazepam—TSPO—hindlimb—sarcoma	0.00225	0.0996	CbGeAlD
Flunitrazepam—TSPO—appendage—sarcoma	0.00193	0.0855	CbGeAlD
Flunitrazepam—UGT1A3—liver—sarcoma	0.00088	0.039	CbGeAlD
Flunitrazepam—UGT1A1—hematopoietic system—sarcoma	0.00083	0.0367	CbGeAlD
Flunitrazepam—CYP2A6—seminal vesicle—sarcoma	0.000736	0.0326	CbGeAlD
Flunitrazepam—TSPO—myometrium—sarcoma	0.000666	0.0295	CbGeAlD
Flunitrazepam—TSPO—embryo—sarcoma	0.000641	0.0284	CbGeAlD
Flunitrazepam—TSPO—seminal vesicle—sarcoma	0.000602	0.0267	CbGeAlD
Flunitrazepam—CYP2C9—mammary gland—sarcoma	0.000572	0.0253	CbGeAlD
Flunitrazepam—TSPO—hematopoietic system—sarcoma	0.000572	0.0253	CbGeAlD
Flunitrazepam—TSPO—connective tissue—sarcoma	0.000551	0.0244	CbGeAlD
Flunitrazepam—GABRA4—tendon—sarcoma	0.000535	0.0237	CbGeAlD
Flunitrazepam—UGT2B7—testis—sarcoma	0.000535	0.0237	CbGeAlD
Flunitrazepam—UGT2B7—liver—sarcoma	0.000505	0.0224	CbGeAlD
Flunitrazepam—TSPO—smooth muscle tissue—sarcoma	0.000504	0.0223	CbGeAlD
Flunitrazepam—TSPO—skin of body—sarcoma	0.000497	0.022	CbGeAlD
Flunitrazepam—GABRA5—testis—sarcoma	0.000488	0.0216	CbGeAlD
Flunitrazepam—GABRA3—testis—sarcoma	0.000455	0.0201	CbGeAlD
Flunitrazepam—CYP2C19—hematopoietic system—sarcoma	0.00045	0.0199	CbGeAlD
Flunitrazepam—TSPO—cardiac atrium—sarcoma	0.000434	0.0192	CbGeAlD
Flunitrazepam—TSPO—uterus—sarcoma	0.000432	0.0191	CbGeAlD
Flunitrazepam—UGT1A1—liver—sarcoma	0.00043	0.019	CbGeAlD
Flunitrazepam—TSPO—lymphoid tissue—sarcoma	0.000403	0.0178	CbGeAlD
Flunitrazepam—TSPO—tendon—sarcoma	0.000379	0.0168	CbGeAlD
Flunitrazepam—CYP1A2—hematopoietic system—sarcoma	0.000367	0.0163	CbGeAlD
Flunitrazepam—TSPO—bone marrow—sarcoma	0.000367	0.0162	CbGeAlD
Flunitrazepam—CYP2A6—liver—sarcoma	0.000362	0.016	CbGeAlD
Flunitrazepam—CYP2B6—hematopoietic system—sarcoma	0.000352	0.0156	CbGeAlD
Flunitrazepam—CYP2C9—hematopoietic system—sarcoma	0.000349	0.0154	CbGeAlD
Flunitrazepam—CYP2E1—seminal vesicle—sarcoma	0.000348	0.0154	CbGeAlD
Flunitrazepam—Ataxia—Thiotepa—sarcoma	0.000341	0.0237	CcSEcCtD
Flunitrazepam—CYP2E1—hematopoietic system—sarcoma	0.00033	0.0146	CbGeAlD
Flunitrazepam—TSPO—testis—sarcoma	0.000313	0.0139	CbGeAlD
Flunitrazepam—CYP2B6—skin of body—sarcoma	0.000306	0.0136	CbGeAlD
Flunitrazepam—Ataxia—Vincristine—sarcoma	0.000302	0.0211	CcSEcCtD
Flunitrazepam—TSPO—liver—sarcoma	0.000296	0.0131	CbGeAlD
Flunitrazepam—Muscular weakness—Vincristine—sarcoma	0.000284	0.0197	CcSEcCtD
Flunitrazepam—CYP3A4—hematopoietic system—sarcoma	0.000266	0.0118	CbGeAlD
Flunitrazepam—Hallucination—Thiotepa—sarcoma	0.00025	0.0174	CcSEcCtD
Flunitrazepam—CYP2B6—lymphoid tissue—sarcoma	0.000248	0.011	CbGeAlD
Flunitrazepam—GABRA2—lymph node—sarcoma	0.000245	0.0109	CbGeAlD
Flunitrazepam—Drowsiness—Mitoxantrone—sarcoma	0.000241	0.0168	CcSEcCtD
Flunitrazepam—Sweating—Vincristine—sarcoma	0.000238	0.0165	CcSEcCtD
Flunitrazepam—CYP2C19—liver—sarcoma	0.000233	0.0103	CbGeAlD
Flunitrazepam—CYP2E1—lymphoid tissue—sarcoma	0.000233	0.0103	CbGeAlD
Flunitrazepam—Sweating—Mitoxantrone—sarcoma	0.000231	0.0161	CcSEcCtD
Flunitrazepam—TSPO—lymph node—sarcoma	0.000227	0.0101	CbGeAlD
Flunitrazepam—Hallucination—Vincristine—sarcoma	0.000221	0.0154	CcSEcCtD
Flunitrazepam—CYP2E1—tendon—sarcoma	0.000219	0.00969	CbGeAlD
Flunitrazepam—Dysarthria—Epirubicin—sarcoma	0.000213	0.0148	CcSEcCtD
Flunitrazepam—Hiccups—Epirubicin—sarcoma	0.000201	0.014	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Dactinomycin—sarcoma	0.000201	0.014	CcSEcCtD
Flunitrazepam—Agitation—Thiotepa—sarcoma	0.000201	0.014	CcSEcCtD
Flunitrazepam—Dysarthria—Doxorubicin—sarcoma	0.000197	0.0137	CcSEcCtD
Flunitrazepam—Malaise—Dactinomycin—sarcoma	0.000195	0.0136	CcSEcCtD
Flunitrazepam—CYP2B6—testis—sarcoma	0.000193	0.00855	CbGeAlD
Flunitrazepam—CYP1A2—liver—sarcoma	0.00019	0.00843	CbGeAlD
Flunitrazepam—Hiccups—Doxorubicin—sarcoma	0.000186	0.013	CcSEcCtD
Flunitrazepam—Anxiety—Thiotepa—sarcoma	0.000185	0.0129	CcSEcCtD
Flunitrazepam—CYP2B6—liver—sarcoma	0.000182	0.00808	CbGeAlD
Flunitrazepam—Discomfort—Dactinomycin—sarcoma	0.000182	0.0127	CcSEcCtD
Flunitrazepam—CYP2E1—testis—sarcoma	0.000181	0.00802	CbGeAlD
Flunitrazepam—CYP2C9—liver—sarcoma	0.000181	0.008	CbGeAlD
Flunitrazepam—Confusional state—Thiotepa—sarcoma	0.00018	0.0125	CcSEcCtD
Flunitrazepam—Agitation—Vincristine—sarcoma	0.000178	0.0124	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Mitoxantrone—sarcoma	0.000175	0.0122	CcSEcCtD
Flunitrazepam—Tachycardia—Thiotepa—sarcoma	0.000174	0.0121	CcSEcCtD
Flunitrazepam—CYP2E1—liver—sarcoma	0.000171	0.00758	CbGeAlD
Flunitrazepam—Malaise—Mitoxantrone—sarcoma	0.00017	0.0118	CcSEcCtD
Flunitrazepam—Anxiety—Mitoxantrone—sarcoma	0.00016	0.0111	CcSEcCtD
Flunitrazepam—Discomfort—Mitoxantrone—sarcoma	0.000159	0.011	CcSEcCtD
Flunitrazepam—Somnolence—Thiotepa—sarcoma	0.000158	0.011	CcSEcCtD
Flunitrazepam—Confusional state—Mitoxantrone—sarcoma	0.000155	0.0108	CcSEcCtD
Flunitrazepam—Fatigue—Thiotepa—sarcoma	0.000154	0.0107	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Vincristine—sarcoma	0.000153	0.0106	CcSEcCtD
Flunitrazepam—Fatigue—Dactinomycin—sarcoma	0.000153	0.0106	CcSEcCtD
Flunitrazepam—Tachycardia—Mitoxantrone—sarcoma	0.00015	0.0105	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Mitoxantrone—sarcoma	0.000149	0.0104	CcSEcCtD
Flunitrazepam—Hypotension—Vincristine—sarcoma	0.000148	0.0103	CcSEcCtD
Flunitrazepam—Feeling abnormal—Thiotepa—sarcoma	0.000147	0.0102	CcSEcCtD
Flunitrazepam—Diplopia—Epirubicin—sarcoma	0.000146	0.0102	CcSEcCtD
Flunitrazepam—Feeling abnormal—Dactinomycin—sarcoma	0.000146	0.0101	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Etoposide—sarcoma	0.000146	0.0101	CcSEcCtD
Flunitrazepam—Hypotension—Mitoxantrone—sarcoma	0.000144	0.01	CcSEcCtD
Flunitrazepam—Malaise—Etoposide—sarcoma	0.000141	0.00985	CcSEcCtD
Flunitrazepam—CYP3A4—liver—sarcoma	0.000138	0.0061	CbGeAlD
Flunitrazepam—Ataxia—Epirubicin—sarcoma	0.000137	0.00956	CcSEcCtD
Flunitrazepam—Somnolence—Mitoxantrone—sarcoma	0.000137	0.00953	CcSEcCtD
Flunitrazepam—Fatigue—Vincristine—sarcoma	0.000136	0.00949	CcSEcCtD
Flunitrazepam—Diplopia—Doxorubicin—sarcoma	0.000135	0.00941	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Epirubicin—sarcoma	0.000133	0.00928	CcSEcCtD
Flunitrazepam—Fatigue—Mitoxantrone—sarcoma	0.000133	0.00924	CcSEcCtD
Flunitrazepam—Discomfort—Etoposide—sarcoma	0.000132	0.00919	CcSEcCtD
Flunitrazepam—Confusional state—Etoposide—sarcoma	0.000129	0.00899	CcSEcCtD
Flunitrazepam—Muscular weakness—Epirubicin—sarcoma	0.000129	0.00897	CcSEcCtD
Flunitrazepam—Asthenia—Thiotepa—sarcoma	0.000128	0.0089	CcSEcCtD
Flunitrazepam—Ataxia—Doxorubicin—sarcoma	0.000127	0.00884	CcSEcCtD
Flunitrazepam—Asthenia—Dactinomycin—sarcoma	0.000127	0.00884	CcSEcCtD
Flunitrazepam—Feeling abnormal—Mitoxantrone—sarcoma	0.000127	0.00883	CcSEcCtD
Flunitrazepam—Tachycardia—Etoposide—sarcoma	0.000125	0.0087	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Etoposide—sarcoma	0.000124	0.00862	CcSEcCtD
Flunitrazepam—Orthostatic hypotension—Doxorubicin—sarcoma	0.000123	0.00859	CcSEcCtD
Flunitrazepam—Hypotension—Etoposide—sarcoma	0.00012	0.00833	CcSEcCtD
Flunitrazepam—Muscular weakness—Doxorubicin—sarcoma	0.000119	0.0083	CcSEcCtD
Flunitrazepam—Dizziness—Thiotepa—sarcoma	0.000118	0.00821	CcSEcCtD
Flunitrazepam—Somnolence—Etoposide—sarcoma	0.000114	0.00792	CcSEcCtD
Flunitrazepam—Asthenia—Vincristine—sarcoma	0.000113	0.00789	CcSEcCtD
Flunitrazepam—Drowsiness—Epirubicin—sarcoma	0.000113	0.00783	CcSEcCtD
Flunitrazepam—Rash—Thiotepa—sarcoma	0.000112	0.00782	CcSEcCtD
Flunitrazepam—Dermatitis—Thiotepa—sarcoma	0.000112	0.00782	CcSEcCtD
Flunitrazepam—Headache—Thiotepa—sarcoma	0.000112	0.00777	CcSEcCtD
Flunitrazepam—Rash—Dactinomycin—sarcoma	0.000112	0.00776	CcSEcCtD
Flunitrazepam—Asthenia—Mitoxantrone—sarcoma	0.00011	0.00769	CcSEcCtD
Flunitrazepam—Fatigue—Etoposide—sarcoma	0.00011	0.00768	CcSEcCtD
Flunitrazepam—Sweating—Epirubicin—sarcoma	0.000108	0.00751	CcSEcCtD
Flunitrazepam—Feeling abnormal—Etoposide—sarcoma	0.000106	0.00734	CcSEcCtD
Flunitrazepam—Dizziness—Vincristine—sarcoma	0.000105	0.00728	CcSEcCtD
Flunitrazepam—Drowsiness—Doxorubicin—sarcoma	0.000104	0.00725	CcSEcCtD
Flunitrazepam—Sweating—Doxorubicin—sarcoma	9.98e-05	0.00695	CcSEcCtD
Flunitrazepam—Rash—Vincristine—sarcoma	9.97e-05	0.00694	CcSEcCtD
Flunitrazepam—Dermatitis—Vincristine—sarcoma	9.96e-05	0.00693	CcSEcCtD
Flunitrazepam—Headache—Vincristine—sarcoma	9.9e-05	0.00689	CcSEcCtD
Flunitrazepam—Rash—Mitoxantrone—sarcoma	9.71e-05	0.00676	CcSEcCtD
Flunitrazepam—Dermatitis—Mitoxantrone—sarcoma	9.7e-05	0.00675	CcSEcCtD
Flunitrazepam—Headache—Mitoxantrone—sarcoma	9.64e-05	0.00671	CcSEcCtD
Flunitrazepam—Asthenia—Etoposide—sarcoma	9.19e-05	0.00639	CcSEcCtD
Flunitrazepam—Dizziness—Etoposide—sarcoma	8.47e-05	0.00589	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Epirubicin—sarcoma	8.16e-05	0.00568	CcSEcCtD
Flunitrazepam—Agitation—Epirubicin—sarcoma	8.08e-05	0.00563	CcSEcCtD
Flunitrazepam—Rash—Etoposide—sarcoma	8.07e-05	0.00562	CcSEcCtD
Flunitrazepam—Dermatitis—Etoposide—sarcoma	8.07e-05	0.00561	CcSEcCtD
Flunitrazepam—Headache—Etoposide—sarcoma	8.02e-05	0.00558	CcSEcCtD
Flunitrazepam—Malaise—Epirubicin—sarcoma	7.93e-05	0.00552	CcSEcCtD
Flunitrazepam—Ill-defined disorder—Doxorubicin—sarcoma	7.55e-05	0.00526	CcSEcCtD
Flunitrazepam—Agitation—Doxorubicin—sarcoma	7.48e-05	0.00521	CcSEcCtD
Flunitrazepam—Anxiety—Epirubicin—sarcoma	7.46e-05	0.00519	CcSEcCtD
Flunitrazepam—Discomfort—Epirubicin—sarcoma	7.4e-05	0.00515	CcSEcCtD
Flunitrazepam—Malaise—Doxorubicin—sarcoma	7.34e-05	0.00511	CcSEcCtD
Flunitrazepam—Dry mouth—Epirubicin—sarcoma	7.32e-05	0.0051	CcSEcCtD
Flunitrazepam—Confusional state—Epirubicin—sarcoma	7.24e-05	0.00504	CcSEcCtD
Flunitrazepam—Tachycardia—Epirubicin—sarcoma	7e-05	0.00488	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Epirubicin—sarcoma	6.94e-05	0.00483	CcSEcCtD
Flunitrazepam—Anxiety—Doxorubicin—sarcoma	6.9e-05	0.00481	CcSEcCtD
Flunitrazepam—Discomfort—Doxorubicin—sarcoma	6.84e-05	0.00476	CcSEcCtD
Flunitrazepam—Dry mouth—Doxorubicin—sarcoma	6.77e-05	0.00472	CcSEcCtD
Flunitrazepam—Hypotension—Epirubicin—sarcoma	6.71e-05	0.00467	CcSEcCtD
Flunitrazepam—Confusional state—Doxorubicin—sarcoma	6.7e-05	0.00466	CcSEcCtD
Flunitrazepam—Tachycardia—Doxorubicin—sarcoma	6.48e-05	0.00451	CcSEcCtD
Flunitrazepam—Hyperhidrosis—Doxorubicin—sarcoma	6.42e-05	0.00447	CcSEcCtD
Flunitrazepam—Somnolence—Epirubicin—sarcoma	6.38e-05	0.00444	CcSEcCtD
Flunitrazepam—Hypotension—Doxorubicin—sarcoma	6.21e-05	0.00432	CcSEcCtD
Flunitrazepam—Fatigue—Epirubicin—sarcoma	6.19e-05	0.00431	CcSEcCtD
Flunitrazepam—Feeling abnormal—Epirubicin—sarcoma	5.91e-05	0.00412	CcSEcCtD
Flunitrazepam—Somnolence—Doxorubicin—sarcoma	5.9e-05	0.00411	CcSEcCtD
Flunitrazepam—Fatigue—Doxorubicin—sarcoma	5.73e-05	0.00399	CcSEcCtD
Flunitrazepam—Feeling abnormal—Doxorubicin—sarcoma	5.47e-05	0.00381	CcSEcCtD
Flunitrazepam—Asthenia—Epirubicin—sarcoma	5.15e-05	0.00358	CcSEcCtD
Flunitrazepam—Asthenia—Doxorubicin—sarcoma	4.76e-05	0.00332	CcSEcCtD
Flunitrazepam—Dizziness—Epirubicin—sarcoma	4.75e-05	0.0033	CcSEcCtD
Flunitrazepam—Rash—Epirubicin—sarcoma	4.53e-05	0.00315	CcSEcCtD
Flunitrazepam—Dermatitis—Epirubicin—sarcoma	4.52e-05	0.00315	CcSEcCtD
Flunitrazepam—Headache—Epirubicin—sarcoma	4.5e-05	0.00313	CcSEcCtD
Flunitrazepam—Dizziness—Doxorubicin—sarcoma	4.39e-05	0.00306	CcSEcCtD
Flunitrazepam—Rash—Doxorubicin—sarcoma	4.19e-05	0.00291	CcSEcCtD
Flunitrazepam—Dermatitis—Doxorubicin—sarcoma	4.18e-05	0.00291	CcSEcCtD
Flunitrazepam—Headache—Doxorubicin—sarcoma	4.16e-05	0.0029	CcSEcCtD
